期刊文献+

胶质细胞瘤染色体1p杂合性缺失:14例研究分析 被引量:1

Loss of Heterozygosity on Chromosome 1p in Glioma of 14 Cases
下载PDF
导出
摘要 背景与目的:少突胶质细胞瘤是胶质瘤中的一种独立类型,近年来的研究显示少突胶质细胞瘤存在着不同于其它胶质瘤类型的分子遗传学改变。其中最显著的就是在大多数少突胶质细胞瘤中出现染色质1p和19q的缺失。同时还发现,有染色质1p及19q缺失病例,对化疗药物敏感性增强,生存期延长,反之预后差。本研究旨在研究胶质细胞瘤染色体1P杂合性缺失的特点。方法:本文使用荧光原位杂交(FISH)技术检测了我院脑外科手术的7例少突胶质细胞瘤及7例其他颅内肿瘤病例的染色体1p。结果:7例少突胶质细胞瘤中4例有1p杂合性缺失,而其他颅内胶质瘤病例中仅有2例出现1p杂合性的缺失。另外1p杂合性缺失的4例病变均为单侧,3例为颞叶,1例为额叶;肿瘤级别上3例为少突胶质细胞瘤(WHOⅡ级),1例为间变性少突胶质细胞瘤(WHOⅢ级)。结论:本研究提示1p杂合性缺失的发生率在少突胶质细胞瘤(4/7)比其它类型胶质瘤(2/7)为高。 BACKGROUND & OBJECTIVE: Ohgodendroglioma is a distinct type among glioma, which shows differences in molecular compositions. Loss of Heterozygosity(LOH) on chromosome lp and 19q is the most common molecular alteration in ohgodendroglioma. It is believed to associate with positive chemosensitivity and favorable prognosis. M]ETHODS: Fluorescence in situ hybridization (FISH) was performed to investigative LOH on chromosome lp and 19q in 7 cases with oligodendroglioma and 7 cases with other types of glioma whom were treated in the department of neurosurgery, PLA General Hospital. RESULTS: LOH in chromosome in lp was detected in 4 oligodendrogliomas(57.1%), while in only 2 cases of other types of glioma(28.5%). CONCLUSIONS: Our results suggest the lp LOH is more frequntly occur in oligodendroglioma tham other type gliomas.
出处 《中国神经肿瘤杂志》 2007年第2期103-107,共5页 Chinese Journal of Neuro-Oncology
关键词 脑肿瘤少突胶质细胞瘤 杂合子 免疫荧光原位杂交 Oligodendrogliomas LOH on chromosomes fluorescence in situ hybridization (FISH)
  • 相关文献

参考文献2

  • 1滕梁红,桂秋萍,宣琪,卢德宏.少突胶质细胞瘤分子遗传学研究进展[J].中华病理学杂志,2004,33(5):471-473. 被引量:2
  • 2Brian Thiessen,John A. Maguire,Kelly McNeil,David Huntsman,Montgomery A. Martin,Doug Horsman. Loss of Heterozygosity for Loci on Chromosome Arms 1p and 10q in Oligodendroglial Tumors: Relationship to Outcome and Chemosensitivity[J] 2003,Journal of Neuro - Oncology(3):271~278

二级参考文献24

  • 1Zlatescu MC, TehraniYazdi A, Sasaki H, et al. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res, 2001, 18: 6713-6715.
  • 2Sasaki H, Zlatescu MC, Betensky RA, et al. Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade ''oligodendroglioma''. J Neuropathol Exp Neurol, 2002, 61:58-63.
  • 3Smith JS, Alderete B, Minn Y, et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene, 1999, 18:4144-4152.
  • 4Zhu JJ, Santarius T, Wu X, et al. Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas. Genes Chromosomes Cancer, 1998, 21:207-216.
  • 5Iuchi T, Namba H, Iwadate Y, et al. Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors. Genes Chromosomes Cancer, 2002, 35:170-175.
  • 6Hashimoto N, Murakami M, Takahashi Y, et al. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p. Cancer, 2003, 97:2254
  • 7Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendroliomas. J Natl Cancer Inst, 1998,90: 1473-1479.
  • 8Hartmann C, Johnk L, Kitange G, et al. Transcript map of the 3.7 Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19. Cancer Res, 2002, 62: 4100-4108.
  • 9Johnson MD, Wu X, Aithmitti N, et al. Peg3/Pw1 is a mediator between p53 and Bax in DNA damage-induced neuronal death. J Biol Chem, 2002, 277: 23000-23007.
  • 10Fujisawa H, Marukawa K, Hasegawa M, et al. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors. J Neurosurg, 2002, 97:1350-1355.

共引文献1

同被引文献20

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部